Literature DB >> 8615310

Patterns of aspirin use in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study.

E Shahar1, A R Folsom, F J Romm, K M Bisgard, P A Metcalf, L Crum, P G McGovern, R G Hutchinson, G Heiss.   

Abstract

To determine correlates of and recent trends in aspirin use in middle-age men and women, we analyzed data from population-based samples selected in four U.S. communities. Aspirin use (during a 2-week period preceding the study examination) was more prevalent in whites than in blacks (30% vs 11%; p < 0.001) and in men than in women among whites (31% vs 28%; p < 0.002) but not blacks (10% in both sexes). In all four race and sex groups, there was a graded positive relation between estimated coronary heart disease (CHD) risk and age-adjusted prevalence of aspirin use. For example, 33% of CHD-free white men who reported diagnoses of hypercholesterolemia and hypertension and had ever smoked reported aspirin use as compared with 25% of their risk factor-free counterparts (p < 0.001). Among men with symptomatic CHD or at high risk for CHD, aspirin use increased by four percentage points between 1987 and 1989 in conjunction with the publication of results from the aspirin primary prevention trials. However, nearly 50% of participants reporting a history of myocardial infarction apparently did not take aspirin regularly.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8615310     DOI: 10.1016/s0002-8703(96)90173-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  21 in total

1.  Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  C R Lee; K E North; M S Bray; D J Couper; G Heiss; D C Zeldin
Journal:  Clin Pharmacol Ther       Date:  2007-05-09       Impact factor: 6.875

2.  Confirmation of reported aspirin use in community studies: utility of serum thromboxane B2 measurement.

Authors:  Nicole Dodge Zantek; Russell V Luepker; Sue Duval; Karen Miller; Niki Oldenburg; Alan T Hirsch
Journal:  Clin Appl Thromb Hemost       Date:  2013-05-07       Impact factor: 2.389

Review 3.  Coronary heart disease risk factors and outcomes in the twenty-first century: findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Hemal Bhatt; Monika Safford; Stephen Glasser
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

4.  Relation of ventricular premature complexes to heart failure (from the Atherosclerosis Risk In Communities [ARIC] Study).

Authors:  Sunil K Agarwal; Ross J Simpson; Pentti Rautaharju; Alvaro Alonso; Eyal Shahar; Mark Massing; Samir Saba; Gerardo Heiss
Journal:  Am J Cardiol       Date:  2011-09-24       Impact factor: 2.778

5.  Aspirin Use for Cardiovascular Disease Prevention in an African American Population: Prevalence and Associations with Health Behavior Beliefs.

Authors:  Jeremy R Van't Hof; Sue Duval; Jeffrey R Misialek; Niki C Oldenburg; Clarence Jones; Milton Eder; Russell V Luepker
Journal:  J Community Health       Date:  2019-06

6.  Use of antithrombotic agents among U.S. stroke survivors, 2000-2006.

Authors:  Eric M Cheng; Stanley N Cohen; Martin L Lee; Stefanie D Vassar; Alex Y Chen
Journal:  Am J Prev Med       Date:  2010-01       Impact factor: 5.043

7.  Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation.

Authors:  L Kristin Newby; Manjushri V Bhapkar; Harvey D White; David J Moliterno; Nancy M Allen LaPointe; David E Kandzari; Freek W A Verheugt; Judith M Kramer; Paul W Armstrong; Robert M Califf
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

8.  Does differential prophylactic aspirin use contribute to racial and geographic disparities in stroke and coronary heart disease (CHD)?

Authors:  Stephen P Glasser; Mary Cushman; Ronald Prineas; Dawn Kleindorfer; Valerie Prince; Zhiying You; Virginia J Howard; George Howard
Journal:  Prev Med       Date:  2008-05-27       Impact factor: 4.018

9.  Antiplatelet drugs and the perioperative period: What every urologist needs to know.

Authors:  Pawan Vasudeva; Apul Goel; Vengetesh K Sengottayan; Satyanarayan Sankhwar; Divakar Dalela
Journal:  Indian J Urol       Date:  2009-07

10.  The Intensive Diet and Exercise for Arthritis (IDEA) trial: design and rationale.

Authors:  Stephen P Messier; Claudine Legault; Shannon Mihalko; Gary D Miller; Richard F Loeser; Paul DeVita; Mary Lyles; Felix Eckstein; David J Hunter; Jeff D Williamson; Barbara J Nicklas
Journal:  BMC Musculoskelet Disord       Date:  2009-07-28       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.